It has not been evaluated by the Food and Drug Administration and is not approved for therapeutic, diagnostic, or human application of any kind
[6] After parenteral delivery, cyanocobalamin binds transcobalamin II, permitting receptor mediated endocytosis into virtually all nucleated cells
Before starting, consult with your healthcare provider to determine suitability
This injectable treatment is designed to support healing, reduce inflammation, and promote overall physical resilience
In several preclinical studies, BPC157 reduced the severity of gut injuries, reversed damage from NSAIDs, and even supported nerve regeneration
These treatments have gained popularity for their reported effects on weight management and well-being